L-arginine ameliorates arylesterase/paraoxonase activity of paraoxonase-1 in hypercholesterolemic rats

Asian Journal of Biochemistry

Volumn 6, Issue 3, 2011, Pages 263-272

  Harisa, Gamal El Din I ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Malondialdehyde; Nitric oxide; Oxidative stress; Protein carbonyl; Total thiols

Indexed keywords

RATTUS;

EID: 79959678429     PISSN: 18159923     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajb.2011.263.272     Document Type: Article

References (44)

1. Amici, A., R.L. Levine, L. Tsai and E.R. Stadtman, 1989. Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. J. Biol. Chem., 264: 3341-3346.
2. Angele, M.K., F. Fitzal, N. Small, M.W. Knofrel and M.G. Schwacha et al., 2000. L-Arginine: Attenuates trauma-hemorrhage induced liver injury. Crit. Care Med., 28: 3242-3248.
3. Asai, R., N. Tomoko, M. Tomohira, O. Ken, I. Kiyohiko, F. Emil and N. Takeshi, 2007. Two mutations converts mammalian xanthine oxidoreductase to high superoxide-productive xanthine oxidase. J. Biochem., 141: 525-534.
4. Aviram, M., M. Rosenblat, S. Billecke, J. Erogul and R. Sorenson et al., 1999. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Rad. Biol. Med., 26: 892-904.
5. Ayub, A., M.I. Mackness, S. Arrol, B. Mackness, J. Patel and P.N. Durrington, 1999. Serum paraoxonase after myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 19: 330-335.
6. Baskol, G., M. Baskol, A. Yurci, O. Ozbakir and M. Yucesoy, 2006. Serum paraoxonase-1 activity and malondialdehyde levels in patient's with ulcerative colitis. Cell Biochem. Funct., 24: 283-286.
7. Beal, M.F., 2002. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med., 32: 797-803.
8. 15N2]-arginine to 15N-labeled nitrate by gas chromatography-mass spectrometry. Nitric Oxide, 11: 1-8.
9. Cimen, M.Y.B., 2008. Free radical metabolism in human erythrocytes. Clin. Chim. Acta, 390: 1-11.
10. Costa, L.G., A. Vitalone, T.B. Cole and C.E. Furlong, 2005. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol., 69: 541-550.
11. Dalle-Donne, I., A. Scaloni, D. Giustarini, E. Cavarra and G. Tell et al. (2005). Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics. Mass Spectrom. Rev., 24: 55-99.
12. Deepa, P.R. and P. Varalakshmi, 2006. Favorable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by low-molecular-weight heparin derivative. Int. J. Cardiol., 106: 338-347.
13. Dirican, M., R. Akca, E. Sarandol and K. Dilek, 2004. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J. Nephrol., 17: 813-818.
14. Draganov, D.I. and B.N. La Du, 2004. Pharmacogenetics of paraoxonase: A brief review. Naunyn-Schmiedeberg's Arch. Pharmacol., 369: 78-88.
15. El-Missiry, M.A., A.I. Othman and M.A. Amer, 2004. L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J. Applied Toxicol., 24: 93-97.
16. Feillet-Coudray, C., T. Sutra, G. Fouret, J. Ramos and C. Wrutniak-Cabello et al., 2009. Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD (P) H oxidase systems. Free Radic. Biol. Med., 46: 624-632.
17. Folch, J., M. Lees and G.H. Sloane-Stanley, 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226: 497-509.
18. Honing, M.L.H., P.J. Morrison, J.D. Banga, E.S.G. Stroes and T.J. Rabelink, 1998. Nitric oxide availability in diabetes mellitus. Diabetes Metab. Rev., 14: 241-249.
19. Hu, M.L., 1994. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol., 233: 380-382.
20. Hurson, M., M.C. Regan, S.J. Kirk, H.L. Wasserkrug and A. Barbul, 1995. Metabolic effects of arginine in a healthy elderly population. J. Parenter. Enter. Nutr., 19: 227-230.
21. Kawano, H., T. Motoyama, N. Hirai, K. Kugiyama, H. Yasue and H. Ogawa, 2002. Endothelial dysfunction in hypercholesterolemia is improved by L-Arginine administration: Possible role of oxidative stress. Atherosclerosis, 161: 375-380.
22. Kumar, S.A., V. Sudhahar and P. Varalakshmi, 2006. Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivative. Prostaglandins Leukot. Essent. Fatty Acids., 75: 25-31.
23. Lass, A., A. Suessenbacher, G. Wolkart, B. Mayer and F. Brunner, 2002. Functional and analytical evidence for scavenging of oxygen radicals by L-Arginine. Mol. Pharmacol., 61: 1081-1088.
24. Levine, R.L., J.A. Williams, E.R. Stadtman and E. Shacter, 1994. Carbonyl assay for determination of oxidatively modified proteins. Methods Enzymol., 233: 346-357.
25. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275.
26. Marjani, A., M. Abolvahab and G. Araz Berdie, 2007. Alterations in plasma lipid peroxidation and erythrocyte superoxide dismutase and glutathione peroxidase enzyme activities during storage of blood. Asian J. Biochem., 2: 118-123.
27. McGrowder, D. and P.D. Brown, 2007. Effect of nitric oxide on glucose transport: In vivo and in vitro studies. Asian J. Biochem., 2: 1-18.
28. Moshage, H., B. Kok, J.R. Huizenga and P.L. Jansen, 1995. Nitrite and nitrate determination in plasma: A critical evaluation. Clin. Chem., 41: 892-896.
29. Nagy, L., M. Nagata and S. Szabo, 2007. Protein and non-protein sulfhydryls and disulfides in gastric mucosa and liver after gastrotoxic chemicals and sucralfate: Possible new targets of pharmacologic agents. World J. Gastroenterol., 13: 2053-2060.
30. Ohkawa, H., N. Ohishi and K. Yagi, 1979. Assay of lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95: 351-358.
31. Ozdemirler, G., S. Kucuk, Y. Orhan, G. Aykac-Toker and M. Uysal, 2001. Lipid and protein oxidation in erythrocyte membranes of hypercholesterolemic subjects. Clin. Biochem., 34: 335-339.
32. Rossitch, Jr. E., E. Alexander 3rd, P.M. Black and J.P. Cooke, 1991. L-Arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J. Clin. Invest., 87: 1295-1299.
33. Rozenberg O., M. Rosenblat, R. Coleman, D.M. Shih and M. Aviram, 2003. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic. Biol. Med., 34: 774-784.
34. Sadeghi-Hashjin, G., M. Abuhosseini and S. Asri-Rezaei, 2009. Role of nitric oxide in the plasma lipid profile in the rabbits. Arch. Med. Sci., 5: 308-312.
35. Schoneich, C. and V.S. Sharov, 2006. Mass spectrometry of protein modifications by reactive oxygen and nitrogen species. Free Radic. Biol. Med., 41: 1507-1520.
36. Serdar, Z., K. Aslan, M. Dirican, E. Sarandol, D. Yesilbursa and A. Serdar, 2006. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. J. Clin. Biochem., 39: 794-803.
37. Shetty, J.K., M. Prakash, M. Verma, S. Tripathy and P. Vickram, 2008. Effect of atorvastatin on paraoxonase activity in patients with hyperlipidemia. Asian J. Biochemistry, 3: 139-142.
38. Shetty, J.K., P. Mungli, T. Sudeshna, V. Manish, K. Nagaraj Shashidhar and S. Pampapathy, 2007. Serum paraoxonase activity and protein thiols in chronic renal failure patients. Asian J. Biochem., 2: 274-278.
39. Subratty, A.H., L.H. Semfa and M.D. Manraj, 2007. TAME-esterase and oxidative stress contribute to dysmetabolic syndrome in dyslipidaemia. Asian J. Biochem., 2: 323-329.
40. Taboada, M.C., B. Rodriguez, R. Millan and I. Miguez, 2005. Role of dietary L-Arginine supplementation on serum parameters and intestinal enzyme activities in rats fed an excess-fat diet. Biomed. Pharmacother., 60: 10-13.
41. Tripathi, P., M. Chandra and M.K. Misra, 2009. Oral administration of L-Arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase. Oxid. Med. Cell. Longev., 2: 231-237.
42. Tsai, H.J., H.F. Shang, C.L. Yeh and S.L. Yeh, 2002. Effects of Arginine supplementation on antioxidant enzyme activity and macrophage response in burned mice. Burns, 28: 258-263.
43. Vega, V.L., L. Mardones, M. Maldonado, S. Nicovani, V. Manriquez, J. Roa and P.H. Ward, 2000. Xanthine oxidase released from reperfused hind limbs mediate kupffer cell activation, neutrophils sequestration and hepatic oxidative stress in rats subjected to tourniquet shock. Shock, 14: 565-571.
44. White, C., D. Parks, R. Patel, J. Shelton, M. Tarpy, B. Freeman and V. Darley-Usmar, 2004. L-Arginine inhibits xanthine oxidase-dependent endothelial dysfunction in hypercholesterolemia. FEBS Lett., 561: 94-98.